Dual checkpoint blockade promising as pre-surgical approach for certain patients with localized bladder cancer
Phase I trial first to evaluate neoadjuvant combination immunotherapy for cisplatin-ineligible patients with high-risk diseaseCredit: The University of Texas MD ...



















